Bio-Path Holdings (BPTH)
(Real Time Quote from BATS)
$0.14 USD
0.00 (0.00%)
Updated Aug 7, 2025 03:28 PM ET
3-Hold of 5 3
F Value A Growth D Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
BPTH 0.14 0.00(0.00%)
Will BPTH be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BPTH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for BPTH
All You Need to Know About Bio-Path (BPTH) Rating Upgrade to Buy
Bio-Path (BPTH) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
BPTH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for BPTH
Bio-Path Holdings (BPTH) Gains Attention Amid Rising Interest in Biotech Stocks | BPTH Stock News
Biotech Alert: Searches spiking for these stocks today
Biotech Alert: Searches spiking for these stocks today
Bio-Path Holdings Faces Leadership Changes and Operational Pause
Bio-Path Holdings to Present at Life Sciences Virtual Investor Forum | BPTH Stock News